Wednesday, June 8, 2011

Opening for post of Immunologist at Cellzome Limited, Cambridge

Cellzome is a world leader in chemoproteomics, transforming the sciences of epigenetics and signal transduction into novel drug candidates in inflammatory diseases and oncology.
We are looking to strengthen our Immunobiology group in Cambridge by recruiting a laboratory-based immunologist to support our ongoing drug discovery efforts. Key responsibilities of the post include:
  • Establishing high quality immunological assays for the evaluation of Cellzome’s lead candidates. 
  • Providing immunology expertise and strategic input into new and existing drug discovery programmes
  • Establishing and maintaining relationships with academic and industrial collaborators in the area of immunology
The ideal candidate for this position will :
  • Hold a PhD in immunology and have an excellent understanding of immune cell signalling and immune mechanisms
  • Have experience in isolating, characterising and culturing primary immune cells, and in a variety of basic and advanced immunological assay techniques including flow cytometry and multiplexed cytokine analysis 
  • Possess excellent team working capabilities, a strong personal sense of responsibility, accountability and attention to detail
  • Have the necessary communication skills to flourish in a multidisciplinary environment
  • Experience in translational research within a clinical setting would be an advantage.
Cellzome offers an excellent compensation package including a competitive salary, bonus scheme, health care scheme and life insurance. The successful applicant will be based at our Chesterford Park site near Cambridge.
Applicants should send their CV, summarising qualifications and experience and quoting reference PH12 to:
James Smith : james.smith@cellzome.com
Tel :             01799 532 800      
Fax : 01799 532 801
Cellzome Limited, 
Chesterford Research Park, 
Little Chesterford, 
Cambridge CB10 1XL
Closing date for applications : Friday 1st July, 2011

No comments:

Post a Comment